# Coronary Slow Flow Phenomenon: A Narrative Literature Review

**Authors:** Khudheeja A Ahmed, Wasifuddin Syed, Juwayria A Ahmed, Mohammed Habeeb Ahmed

PMC · DOI: 10.7759/cureus.88657 · Cureus · 2025-07-24

## TL;DR

This paper reviews coronary slow flow, a condition where contrast moves slowly in coronary arteries without blockage, affecting young males and causing chest pain and other serious symptoms.

## Contribution

The paper provides a narrative review of the clinical relevance, possible causes, and treatment approaches for coronary slow flow phenomenon.

## Key findings

- Coronary slow flow is associated with endothelial dysfunction and may involve inflammation and atherosclerosis.
- Oral calcium channel blockers have been used successfully to treat patients with coronary slow flow.
- The condition is distinct from similar presentations like vasospasm and post-procedural slow flow.

## Abstract

Coronary slow flow (CSF) is understood to be a clinical condition during which angiographic findings show the slowed filling of contrast in the coronary vasculature in individuals without a history of coronary artery disease (CAD). Other names for this entity include, less commonly, Syndrome Y and primary CSF. Though clinically underestimated, it is a recognized phenomenon and is documented in a subset of patients with symptoms resembling acute coronary syndrome. The most common group with CSF is that of young males with a history of smoking. CSF is clinically relevant, with patients presenting with chest pain, arrhythmias, and even sudden death. CSF therefore markedly impairs patients’ quality of life. Particular treatments for CSF are not specified, though oral calcium channel blockers (CCBs) have been used successfully. Much research has been done regarding CSF, and it is thought to reflect endothelial dysfunction. Factors such as inflammation, atherosclerosis, hematological disorders, and structural components may also contribute to CSF’s pathology, though CSF’s exact cause is still not fully understood by clinicians. CSF is also distinct from conditions with similar presentations, such as post-procedural slow flow and vasospasm. Since the importance of CSF is being understood to be clinically relevant by clinicians, research is recommended to better further elucidate the pathology of this phenomenon.

## Linked entities

- **Diseases:** coronary artery disease (MONDO:0005010), acute coronary syndrome (MONDO:0005542)

## Full-text entities

- **Diseases:** Syndrome Y (MESH:C536297), vasospasm (MESH:D020301), hematological disorders (MESH:D006402), arrhythmias (MESH:D001145), inflammation (MESH:D007249), acute coronary syndrome (MESH:D054058), chest pain (MESH:D002637), sudden death (MESH:D003645), atherosclerosis (MESH:D050197), CAD (MESH:D003324)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12289443/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12289443/full.md

---
Source: https://tomesphere.com/paper/PMC12289443